Published in J Pathol on July 01, 1996
Vascular anatomy defines sites of indomethacin induced jejunal ulceration along the mesenteric margin. Gut (1997) 0.99
Ulceration of the ileum in Crohn's disease: correlation with vascular anatomy. J Clin Pathol (1997) 0.84
Vascular anatomy in gastrointestinal inflammation. J Clin Pathol (1999) 0.77
The effects of lectins on indomethacin-induced small intestinal ulceration. Int J Exp Pathol (2003) 0.77
Enantiomers of flurbiprofen can distinguish key pathophysiological steps of NSAID enteropathy in the rat. Gut (1998) 0.76
Retracted Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet (1998) 36.93
Is measles vaccination a risk factor for inflammatory bowel disease? Lancet (1995) 6.75
Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet (1989) 5.70
A simple clinical colitis activity index. Gut (1998) 4.35
Effect of cimetidine on 24-hour intragastric acidity in normal subjects. Gut (1976) 3.75
Hepatocytes from non-hepatic adult stem cells. Nature (2000) 3.27
Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity. Gut (1984) 3.18
Granulomatous vasculitis in Crohn's disease. Gastroenterology (1991) 2.72
24-hour control of intragastric acidity by cimetidine in duodenal-ulcer patients. Lancet (1975) 2.67
Genetics versus environment in inflammatory bowel disease: results of a British twin study. BMJ (1996) 2.64
MMR vaccination and autism. Lancet (1999) 2.55
Hepatic angiomyolipoma: a clinicopathologic study of 30 cases and delineation of unusual morphologic variants. Am J Surg Pathol (1999) 2.53
Measles, mumps, rubella vaccine: through a glass, darkly. Adverse Drug React Toxicol Rev (2000) 2.47
PGP 9.5--a new marker for vertebrate neurons and neuroendocrine cells. Brain Res (1983) 2.41
Paramyxovirus infections in childhood and subsequent inflammatory bowel disease. Gastroenterology (1999) 2.39
Effect of daily oral omeprazole on 24 hour intragastric acidity. Br Med J (Clin Res Ed) (1983) 2.30
Detection of herpesvirus DNA in the large intestine of patients with ulcerative colitis and Crohn's disease using the nested polymerase chain reaction. J Med Virol (1992) 2.22
Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori. Gut (1990) 2.13
Perinatal measles infection and subsequent Crohn's disease. Lancet (1994) 2.11
Potential viral pathogenic mechanism for new variant inflammatory bowel disease. Mol Pathol (2002) 2.07
Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection. Liver (1999) 2.01
Transmucosal penetration of bismuth particles in the human stomach. Gastroenterology (1992) 2.00
Crohn's disease after in-utero measles virus exposure. Lancet (1996) 1.98
Model of medical treatment for duodenal ulcer. Lancet (1981) 1.98
PGP 9.5, a new marker for human neuroendocrine tumours. Histopathology (1985) 1.97
Evaluation of the polymerase chain reaction for detecting the urease C gene of Helicobacter pylori in gastric biopsy samples and dental plaque. J Med Microbiol (1993) 1.94
An appraisal of the histopathological assessment of liver fibrosis. Gut (2006) 1.87
24-hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer during oral administration of cimetidine and atropine. Gut (1977) 1.87
Proposal for standardized criteria for the diagnosis of benign, borderline, and malignant hepatocellular lesions arising in chronic advanced liver disease. Am J Surg Pathol (1993) 1.84
Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers. J Infect Dis (1999) 1.84
Inhibition of food-stimulated gastric acid secretion by cimetidine. Gut (1976) 1.82
DNA patterns of Helicobacter pylori isolated from gastric antrum, body, and duodenum. Gastroenterology (1992) 1.80
A survey of dyspepsia in Great Britain. Aliment Pharmacol Ther (1996) 1.79
Evidence of persistent measles virus infection in Crohn's disease. J Med Virol (1993) 1.76
QBEnd/10: a new immunostain for the routine diagnosis of Kaposi's sarcoma. J Pathol (1990) 1.76
Inherited disorders of coagulation appear to protect against inflammatory bowel disease. Gastroenterology (1995) 1.69
Characterization of the humoral immune response to Klebsiella species in inflammatory bowel disease and ankylosing spondylitis. Br J Rheumatol (1998) 1.69
Serum -glytamyl transpeptidase activity in liver disease. Gut (1972) 1.69
Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism. Mol Psychiatry (2002) 1.67
The immunolocalization of protein gene product 9.5 using rabbit polyclonal and mouse monoclonal antibodies. Br J Exp Pathol (1988) 1.67
Macrophage heterogeneity in normal colonic mucosa and in inflammatory bowel disease. Gut (1988) 1.67
The absorption of bismuth from oral doses of tripotassium dicitrato bismuthate. Aliment Pharmacol Ther (1989) 1.65
Twenty-four-hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole. Aliment Pharmacol Ther (1987) 1.62
Intragastric bacterial activity and nitrosation before, during, and after treatment with omeprazole. Br Med J (Clin Res Ed) (1984) 1.61
Transjugular liver biopsy: how good is it for accurate histological interpretation? Gut (2006) 1.61
Is proximal demarcation of ulcerative colitis determined by the territory of the inferior mesenteric artery? Lancet (1995) 1.58
Methotrexate and liver fibrosis in people with psoriasis: a systematic review of observational studies. Br J Dermatol (2014) 1.57
Effects of isolation and culture on prostaglandin synthesis by porcine aortic endothelial and smooth muscle cells. J Cell Physiol (1982) 1.55
Bismuth accumulates in the body during treatment with tripotassium dicitrato bismuthate. Aliment Pharmacol Ther (1989) 1.52
Healing of gastric ulcer during treatment with cimetidine. Lancet (1976) 1.52
The effect of ranitidine, cimetidine or famotidine on low-dose post-prandial alcohol absorption. Aliment Pharmacol Ther (1991) 1.51
Helicobacter pylori and gastroduodenal secretory function. Gastroenterology (1996) 1.50
Hepatocellular carcinoma arising in an adenoma: value of QBend 10 immunostaining in diagnosis of liver cell carcinoma. Histopathology (1996) 1.49
Small hepatocellular carcinomas in cirrhotic explant livers: identification by macroscopic examination and lipiodol localization. Hepatology (1997) 1.48
Perinatal and childhood risk factors for inflammatory bowel disease: a case-control study. Eur J Gastroenterol Hepatol (1995) 1.46
The initial care of newborn infants and subsequent hay fever. Allergy (2000) 1.46
Duodenal ulcers that will not heal. Gut (1984) 1.45
Measles IgM immunoreactivity in patients with inflammatory bowel disease. Ital J Gastroenterol Hepatol (1998) 1.44
Genomic heterogeneity in synchronous hepatocellular carcinomas. Gut (1999) 1.44
Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. Hepatology (2000) 1.44
Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B. J Viral Hepat (2000) 1.43
Twenty-four hour intragastric acidity and plasma gastrin concentration profiles in female and male subjects. Clin Sci (Lond) (1991) 1.42
Pertussis infection in childhood and subsequent type 1 diabetes mellitus. Diabet Med (2002) 1.40
Review article: the pharmacological implications of leucocyte-endothelial cell interactions in Crohn's disease. Aliment Pharmacol Ther (1991) 1.40
Vascular invasion and herniation by hepatocellular carcinoma in cirrhosis: A wolf in sheep's clothing? Arch Pathol Lab Med (2005) 1.39
Management issues for debate: the problems in perspective. Aliment Pharmacol Ther (1993) 1.39
Twenty-four-hour intragastric acidity and plasma gastrin concentration in healthy subjects and patients with duodenal or gastric ulcer, or pernicious anaemia. Aliment Pharmacol Ther (1987) 1.35
A randomized placebo-controlled trial of a humanized monoclonal antibody to alpha4 integrin in active Crohn's disease. Gastroenterology (2001) 1.34
Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update. J Hepatol (2007) 1.33
A possible vascular factor in the aetiology of duodenal ulceration. Br J Surg (1971) 1.31
Neurone specific enolase: an aid to the diagnosis of melanoma and neuroblastoma. Histopathology (1982) 1.27
Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism. Br J Cancer (2010) 1.25
Antineutrophil cytoplasm autoantibodies against bactericidal/permeability-increasing protein in inflammatory bowel disease. Gut (1997) 1.23
Infant mortality and the incidence of inflammatory bowel disease. Lancet (1997) 1.23
Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection. J Viral Hepat (2002) 1.22
Comparison of PCR-based restriction length polymorphism analysis of urease genes with rRNA gene profiling for monitoring Helicobacter pylori infections in patients on triple therapy. J Clin Microbiol (1994) 1.22
Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism. J Pediatr (2001) 1.21
Relief of duodenal ulcer sysmptons by oral metiamide. Br Med J (1975) 1.20
Clostridium difficile and inflammatory bowel disease. Gut (1983) 1.20
The value of rectal biopsy in distinguishing self-limited colitis from early inflammatory bowel disease. Q J Med (1987) 1.18
Eradication of Helicobacter pylori abolishes 24-hour hypergastrinaemia: a prospective study in healthy subjects. Aliment Pharmacol Ther (1991) 1.17
Blood supply to the human gastroduodenal mucosa with special reference to the ulcer-bearing areas. J Anat (1974) 1.17
Letter: Serum lysozyme in inflammatory bowel disease. Lancet (1975) 1.16